Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota
International Journal of Molecular Sciences · 25.01.2023 · 24 (3) · 2389
DOI: 10.3390/ijms24032389 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.01.2023. Verfasst von Mariana Luz-Veiga und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Biotecnologia e Química Fina (CBQF)-Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Bo…. Hauptthemen laut MEDLINE: Cannabidiol, Cannabinoids, Cannabis. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Agencia de Inovacao.
Abstract (Originalsprache)
Cannabidiol (CBD) and cannabigerol (CBG) are two pharmacologically active phytocannabinoids of Cannabis sativa L. Their antimicrobial activity needs further elucidation, particularly for CBG, as reports on this cannabinoid are scarce. We investigated CBD and CBG’s antimicrobial potential, including their ability to inhibit the formation and cause the removal of biofilms. Our results demonstrate that both molecules present activity against planktonic bacteria and biofilms, with both cannabinoids removing mature biofilms at concentrations below the determined minimum inhibitory concentrations. We report for the first time minimum inhibitory and lethal concentrations for Pseudomonas aeruginosa and Escherichia coli (ranging from 400 to 3180 µM), as well as the ability of cannabinoids to inhibit Staphylococci adhesion to keratinocytes, with CBG demonstrating higher activity than CBD. The value of these molecules as preservative ingredients for cosmetics was also assayed, with CBG meeting the USP 51 challenge test criteria for antimicrobial effectiveness. Further, the exact formulation showed no negative impact on skin microbiota. Our results suggest that phytocannabinoids can be promising topical antimicrobial agents when searching for novel therapeutic candidates for different skin conditions. Additional research is needed to clarify phytocannabinoids’ mechanisms of action, aiming to develop practical applications in dermatological use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Biotecnologia e Química Fina (CBQF)-Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.
- Amyris Bio Products Portugal, Unipessoal Lda, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.
ORCID-Profile: Mariana Luz-Veiga, Manuela Amorim, Ana L S Oliveira, Sara Silva, Lígia L Pimentel, Luís M Rodríguez-Alcalá, João Azevedo-Silva
Förderung
- Fundação para a Ciência e Tecnologia
- Agencia de Inovacao
Zitieren
APA
Luz-Veiga, M., Amorim, M., Pinto-Ribeiro, I., Oliveira, A. L. S., Silva, S., Pimentel, L. L., Rodríguez-Alcalá, L. M., Madureira, R., Pintado, M., Azevedo-Silva, J., & Fernandes, J. (2023). Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota. International Journal of Molecular Sciences, 24(3), 2389. https://doi.org/10.3390/ijms24032389
Vancouver
Luz-Veiga M, Amorim M, Pinto-Ribeiro I, Oliveira ALS, Silva S, Pimentel LL, et al. Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota. International Journal of Molecular Sciences. 2023;24(3):2389. doi:10.3390/ijms24032389
BibTeX
@article{LuzVeiga2023,
author = {Luz-Veiga, Mariana and Amorim, Manuela and Pinto-Ribeiro, Inês and Oliveira, Ana L S and Silva, Sara and Pimentel, Lígia L and Rodríguez-Alcalá, Luís M and Madureira, Raquel and Pintado, Manuela and Azevedo-Silva, João and Fernandes, João},
title = {Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {2389},
doi = {10.3390/ijms24032389}
}
EUVIMED